Bilitool provides care recommendations for newborn infants with jaundice (hyperbilirubinemia) at risk for bilirubin encephalopathy and kernicterus. The primary outcome measure was the proportion of phototherapy initiation events consistent with recommended tb thresholds. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation
Pediatrics 2022;150 (3):e2022058859 [full text] [pubmed] We developed and implemented premie bilirecs (pbr), a novel cds tool for phototherapy initiation in preterm infants from 27 through 34 weeks postmenstrual age Bilitool™ is designed to help clinicians assess the risks toward the development of hyperbilirubinemia or jaundice in newborns over 35 weeks gestational age.
It implements the 2022 american academy of pediatrics guideline for the management of hyperbilirubinemia in newborn infants at 35 or more weeks of gestation.
